Edwards Lifesciences Corp. (EW) Tops Q1 EPS by 9c; Increases FY11 EPS Outlook, Guides Q2
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $85.88 -1.69%
EPS Growth %: +10.4%
Financial Fact:
Interest (income) expense, net: 2.1M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +10.4%
Financial Fact:
Interest (income) expense, net: 2.1M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Edwards Lifesciences Corp. (NYSE: EW) reported Q1 EPS of $0.51, $0.09 better than the analyst estimate of $0.42. Revenue for the quarter came in at $404.5 million versus the consensus estimate of $384.15 million.
Sees Q2 2011 EPS of $0.49-$0.51, versus the consensus of $0.47.
Increases FY2011 EPS form $1.91 - $1.97 to $2.01-$2.07, versus the consensus of $1.95. Sees FY2011 revenue of $1.66-$1.74 billion, versus the consensus of $1.63 billion.
Sees Q2 2011 EPS of $0.49-$0.51, versus the consensus of $0.47.
Increases FY2011 EPS form $1.91 - $1.97 to $2.01-$2.07, versus the consensus of $1.95. Sees FY2011 revenue of $1.66-$1.74 billion, versus the consensus of $1.63 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AeroVironment restates quarterly financials, citing $89M goodwill error
- Nucor guides Q2 2026 earnings to $4.70-$4.80 per diluted share
- Smith & Wesson Brands (SWBI) Tops Q4 EPS by 15c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
